Regulation of TCR-mediated T cell activation by TNF-RII

Journal of Leukocyte Biology

Volumn 74, Issue 4, 2003, Pages 572-582

  Aspalter, Rosa Maria ^a   Eibl, Martha Marianne ^a   Wolf, Hermann Maximilian ^a  

^a Immunology Outpatient Clinic   (Austria)

Author keywords

Ca++ flux; IL 2; T cell receptor; TNF

Indexed keywords

GAMMA INTERFERON RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INTRACELLULAR MEMBRANE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD28; CELLS, CULTURED; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0346100668     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0303112     Document Type: Article

References (46)

1. Beyaert, R., Fiers, W. (1998) Tumor necrosis factor and lymphotoxin. In Cytokines (A. Mire-Sluis, R. Thorpe, eds.), San Diego, CA, Academic, 335-360.
2. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., Williamson, B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
3. Sidhu, R. S., Bollon, A. P. (1993) Tumor necrosis factor activities and cancer therapy - a perspective. Pharmacol. Ther. 57, 79-128.
4. Heller, R. A., Kronke, M. (1994) Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol. 126, 5-9.
5. Heyninck, K., Beyaert, R. (2001) Crosstalk between NF-kappaB-activating and apoptosis-inducing proteins of the TNF-receptor complex. Mol. Cell Biol. Res. Commun. 4, 259-265.
6. Nakano, K., Okugawa, K., Furuichi, H., Matsui, Y., Sohmura, Y. (1989) Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant human tumor necrosis factor. Cell. Immunol. 120, 154-164.
7. Eisenthal, A., Rosenberg, S. A. (1989) The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha. J. Immunol. 142, 2307-2313.
8. Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C., Palladino Jr., M. A., Goeddel, D. V. (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88, 9292-9296.
9. Tartaglia, L. A., Goeddel, D. V., Reynolds, C., Figari, I. S., Weber, R. F., Fendly, B. M., Palladino Jr., M. A. (1993) Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151, 4637-4641.
10. Cope, A. P., Liblau, R. S., Yang, X. D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., McDevitt, H. O. (1997) Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 185, 1573-1584.
11. Scheurich, P., Thoma, B., Ucer, U., Pfizenmaier, K. (1987) Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J. Immunol. 138, 1786-1790.
12. Kehrl. J. H., Miller, A., Fauci, A. S. (1987) Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J. Exp. Med. 166, 786-791.
13. Aversa, G., Punnonen, J., de Vries, J. E. (1993) The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177, 1575-1585.
14. Page, D. M., Roberts, E. M., Peschon, J. J., Hedrick, S. M. (1998) TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160, 120-133.
15. Bromberg, J. S., Chavin, K. D., Kunkel, S. L. (1992) Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo. J. Immunol. 148, 3412-3417.
16. Bean, A. G., Roach, D. R., Briscoe, H., France, M. P., Korner, H., Sedgwick, J. D., Britton, W. J. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162, 3504-3511.
17. Pimentel-Muinos, F. X., Mazana, J., Fresno, M. (1995) Biphasic control of nuclear factor-kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha. Eur. J. Immunol. 25, 179-186.
18. Isomaki, P., Panesar, M., Annenkov, A., Clark, J. M., Foxwell, B. M., Chernajovsky, Y., Cope, A. P. (2001) Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J. Immunol. 166, 5495-5507.
19. Vandenabeele, P., Declercq, W., Vercammen, D. Van de Craen, M., Grooten, J., Loetscher, H., Brockhaus, M., Lesslauer, W., Fiers, W. (1992) Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J. Exp. Med. 176, 1015-1024.
20. Grell, M., Becke, F. M., Wajant, H., Mannel, D. N., Scheurich, P. (1998) TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur. J. Immunol. 28, 257-263.
21. Lenschow, D. J., Walunas, T. L., Bluestone, J. A. (1996) CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
22. Cameron, A. J., Harnett, M. M., Allen, J. M. (2001) Differential recruitment of accessory molecules by FcgammaRI during monocyte differentiation. Eur. J. Immunol. 31, 2718-2725.
23. Thon, V., Wolf, H. M., Sasgary, M., Litzman, J., Samstag, A., Hauber, I., Lokaj, J., Eibl, M. M. (1997) Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients. Clin. Exp. Immunol. 110, 174-181.
24. Rijkers, G. T., Justement, L. B., Griffioen, A. W., Cambier, J. C. (1990) Improved method for measuring intracellular Ca++ with fluo-3. Cytometry 11, 923-927.
25. Lucas, P. J., Negishi, I., Nakayama, K., Fields, L. E., Loh, D. Y. (1995) Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154, 5757-5768.
26. Rudd, C. E. (1999) Adaptors and molecular scaffolds in immune cell signaling. Cell 96, 5-8.
27. Joseph, S. B., Miner, K. T., Croft, M. (1998) Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur. J. Immunol. 28, 277-289.
28. Sepulveda, H., Cerwenka, A., Morgan, T., Dutton, R. W. (1999) CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol. 163, 1133-1142.
29. Pimentel-Muinos, F. X., Munoz-Fernandez, M. A., Fresno, M. (1994) Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152, 5714-5722.
30. Yokota, S., Geppert, T. D., Lipsky, P. E. (1988) Enhancement of antigen-and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J. Immunol. 140, 531-536.
31. Munoz-Fernandez, M. A., Pimentel-Muinos, F. X., Alonso, M. A., Campanero, M., Sanchez-Madrid, F., Silva, A., Alonso, J. L., Fresno, M. (1990) Synergy of tumor necrosis factor with protein kinase C activators on T cell activation. Eur. J. Immunol. 20, 605-610.
32. Munoz-Fernandez, M. A., Pimentel-Muinos, F. X., Gonzalez, A., Gambon, F., Alvarez-Vallina, L., Fresno, M. (1992) Differential effect of tumour necrosis factor on human thymocyte subpopulations. Immunology 76, 439-445.
33. Kim, E. Y., Teh, H. S. (2001) TNF type 2 receptor (p75) lowers the threshold of T cell activation. J. Immunol. 167, 6812-6820.
34. Ruuls, S. R., Hoek, R. M., Ngo, V. N., McNeil, T., Lucian, L. A., Janatpour, M. J., Korner, H., Scheerens, H., Hessel, E. M., Cyster, J. G., McEvoy, L. M., Sedgwick, J. D. (2001) Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15, 533-543.
35. Cantrell, D. (1996) T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14, 259-274.
36. Witherden, D. A., Boismenu, R., Havran, W. L. (2000) CD81 and CD28 costimulate T cells through distinct pathways. J. Immunol. 165, 1902-1909.
37. Dickensheets, H. L., Freeman, S. L., Donnelly, R. P. (2000) Interleukin-12 differentially regulates expression of IFN-gamma and interleukin-2 in human T lymphoblasts. J. Interferon Cytokine Res. 20, 897-905.
38. Rafiq, K., Kasran, A., Peng, X., Warmerdam, P. A., Coorevits, L., Ceuppens, J. L., Van Gool, S. W. (1998) Cyclosporin A increases IFN-gamma production by T cells when co- stimulated through CD28. Eur. J. Immunol. 28, 1481-1491.
39. Herring, A. C., Lee, J., McDonald, R. A., Toews, G. B., Huffnagle, G. B. (2002) Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect. Immun. 70, 2959-2964.
40. Hehner, S. P., Hofmann, T. G., Dienz, O., Droge, W., Schmitz, M. L. (2000) Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription. J. Biol. Chem. 275, 18160-18171.
41. Rothe, M., Wong, S. C., Henzel, W. J., Goeddel, D. V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
42. Ghosh, S., May, M. J., Kopp, E. B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
43. Krasnow, S. W., Zhang, L. Q., Leung, K. Y., Osborn, L., Kunkel, S., Nabel, G. J. (1991) Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells. Cytokine 3, 372-379.
44. Tsitsikov, E. N., Laouini, D., Dunn, I. F., Sannikova, T. Y., Davidson, L., Alt, F. W., Geha, R. S. (2001) TRAF1 is a negative regulator of TNF signaling. Enhanced TNF signaling in TRAF1-deficient mice. Immunity 15, 647-657.
45. de Waal, M. R., Yssel, H., de Vries, J. E. (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150, 4754-4765.
46. Glickstein, L., Macphail, S., Stutman, O. (1996) Uncoupling IL-2 production from apoptosis and TNF production by changing the signal through the TCR. J. Immunol. 156, 2062-2067.